$ABT just dropped a $670M settlement bomb to close out the Gill verdict plus ~2,000 NEC claims. They're walking away from appeals entirely.

The kicker? Abbott's still standing firm that their preterm formulas are safe and medically necessary. Classic corporate math: sometimes the cost of fighting exceeds the cost of settling, even when you believe you're right.

This clears a major overhang for Abbott shareholders. Legal uncertainty was weighing on the stock, and now they've drawn a line under it. Watch how the Street reprices this now that the tail risk is quantified and contained.